Research
Open Access
Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study
Teumzghi F. Mebrahtu, Ann W. Morgan, Robert M. West, Paul M. Stewart and Mar Pujades-Rodriguez
CMAJ March 23, 2020 192 (12) E295-E301; DOI: https://doi.org/10.1503/cmaj.191012
Teumzghi F. Mebrahtu
Leeds Institute of Biomedical and Clinical Sciences (Mebrahtu); Leeds Institute of Cardiovascular and Metabolic Medicine (Morgan), School of Medicine, University of Leeds; NIHR Biomedical Research Centre (Morgan, Stewart), Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital; Leeds Institute of Health Sciences, (West, Pujades-Rodriguez), School of Medicine; Dean’s office, Faculty of Medicine & Health (Stewart), University of Leeds, Leeds, UK
PhDAnn W. Morgan
Leeds Institute of Biomedical and Clinical Sciences (Mebrahtu); Leeds Institute of Cardiovascular and Metabolic Medicine (Morgan), School of Medicine, University of Leeds; NIHR Biomedical Research Centre (Morgan, Stewart), Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital; Leeds Institute of Health Sciences, (West, Pujades-Rodriguez), School of Medicine; Dean’s office, Faculty of Medicine & Health (Stewart), University of Leeds, Leeds, UK
PhDRobert M. West
Leeds Institute of Biomedical and Clinical Sciences (Mebrahtu); Leeds Institute of Cardiovascular and Metabolic Medicine (Morgan), School of Medicine, University of Leeds; NIHR Biomedical Research Centre (Morgan, Stewart), Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital; Leeds Institute of Health Sciences, (West, Pujades-Rodriguez), School of Medicine; Dean’s office, Faculty of Medicine & Health (Stewart), University of Leeds, Leeds, UK
DPhilPaul M. Stewart
Leeds Institute of Biomedical and Clinical Sciences (Mebrahtu); Leeds Institute of Cardiovascular and Metabolic Medicine (Morgan), School of Medicine, University of Leeds; NIHR Biomedical Research Centre (Morgan, Stewart), Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital; Leeds Institute of Health Sciences, (West, Pujades-Rodriguez), School of Medicine; Dean’s office, Faculty of Medicine & Health (Stewart), University of Leeds, Leeds, UK
MBChB, MDMar Pujades-Rodriguez
Leeds Institute of Biomedical and Clinical Sciences (Mebrahtu); Leeds Institute of Cardiovascular and Metabolic Medicine (Morgan), School of Medicine, University of Leeds; NIHR Biomedical Research Centre (Morgan, Stewart), Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital; Leeds Institute of Health Sciences, (West, Pujades-Rodriguez), School of Medicine; Dean’s office, Faculty of Medicine & Health (Stewart), University of Leeds, Leeds, UK
PhDData supplements
Online appendix
Related Articles
In this issue
Article tools
Respond to this article
Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study
Teumzghi F. Mebrahtu, Ann W. Morgan, Robert M. West, Paul M. Stewart, Mar Pujades-Rodriguez
CMAJ Mar 2020, 192 (12) E295-E301; DOI: 10.1503/cmaj.191012
Jump to section
Related Articles
Cited By...
- Retrospective cohort study investigating synergism of air pollution and corticosteroid exposure in promoting cardiovascular and thromboembolic events in older adults
- A retrospective cohort study investigating synergism of air pollution and corticosteroid exposure in promoting cardiovascular and thromboembolic events in older adults
- Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
- Metabolic adverse events associated with systemic corticosteroid therapy--a systematic review and meta-analysis
- Even low doses of steroids increase the risk of cardiovascular disease in people with inflammatory diseases